Fanapanel

DB12393InvestigationalSmall molecule

Fanapanel has been investigated for the treatment of Visual Acuity.

Mechanism: Pharmacologically active on Glutamate receptor 1, Glutamate receptor 2, and Glutamate receptor 4
Curator reviewed
Formula / weight: C₁₄H₁₅F₃N₃O₆P · 409.2544 g/mol (avg)
Code names: ZK-200775

Resolves to

Compound

Structure

InChIKeyWZMQMKNCWDCCMT-UHFFFAOYSA-NSMILESOP(O)(=O)CN1C(=O)C(=O)NC2=C1C=C(N1CCOCC1)C(=C2)C(F)(F)F

Targets

What you can answer from here — as of July 07, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

20+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fanapanel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.